Effect of intrathecal agmatine on inflammation-induced thermal hyperalgesia in rats.
Agmatine, an endogenous ligand, interacts both with the alpha2-adrenoceptors and with the imidazoline binding sites. The effect of intrathecally administered agmatine on carrageenan-induced thermal hyperalgesia was investigated by means of a paw-withdrawal test in rats. The effect of agmatine on morphine-induced anti-hyperalgesia was also studied. Intrathecal agmatine in doses larger than 250 microg caused a decrease in the pain threshold, with vocalization and agitation lasting for several hours in all animals. Agmatine alone at 1-100 microg did not give rise to any change in the thermal withdrawal threshold in the contralateral non-inflamed paw. Agmatine pretreatment was found to dose-dependently attenuate the thermal hyperalgesia induced by intraplantar carrageenan. The effect of 100 microg agmatine was completely lost by 60 min, whereas the effect of 50 microg was of similar magnitude but exhibited a longer duration. Agmatine posttreatment had a slighter effect. Agmatine pretreatment (100 microg) together with 1 microg morphine (subeffective dose) has significantly higher anti-hyperalgesic effect then the individual compounds by themselves. These are the first data demonstrating the behavioral and anti-hyperalgesic effects of intrathecal agmatine. The results reveal important interactions between intrathecal agmatine and opioids in thermal hyperalgesia.
Horváth
G
G
Department of Physiology, Albert Szent-Gyrgyi Medical University, Szeged, Hungary. horvath@phys.szote.u-szeged.hu
Kékesi
G
G
Dobos
I
I
Szikszay
M
M
Klimscha
W
W
Benedek
G
G
D000376:Agmatine / Q000494:pharmacology*; D000701:Analgesics, Opioid / Q000494:pharmacology; D000818:Animals; D002351:Carrageenan / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006614:Hindlimb / Q000187:drug effects / Q000294:innervation / Q000473:pathology; D006930:Hyperalgesia / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control*; D007249:Inflammation / Q000503:physiopathology; D007278:Injections, Spinal; D008297:Male; D009020:Morphine / Q000494:pharmacology; D017288:Pain Threshold / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
D000701:Analgesics, Opioid; D000376:Agmatine; D009020:Morphine; D002351:Carrageenan